CompoAtlas

VITAMINE C ACÉROLA BIO 200 MG

Food supplement declared in France, decision dated 24 January 2025

VITAMINE C ACÉROLA BIO 200 MG, from Sunday Natural Products GmbH, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Malpighia glabra 2,000 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
Sunday Natural Products GmbH
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 gélules
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Children (under 12), Young children (aged 1 to 3), Infants (under 1 year), Children (under 6), Children (under 10)

Declaration 4886, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Malpighia glabra L.FruitPoudre (de plantes séchées ou broyées)2,000 mg

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “VITAMINE C ACÉROLA BIO 200 MG: composition and regulation”, https://compoatlas.com/en/supplements/products/4886-vitamine-c-acerola-bio-200-mg, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line